- Tuesday, October 3, 2023
8:00 AM – 8:07 AM PT
213 - Polymetastatic Recurrence-Free Survival in Patients with Repeat Oligometastases on the SABR-5 TrialLocation: Room 4Presenter: – BC Cancer - Vancouver Centre
Wei Liu, MD – BC Cancer - Vancouver Centre ### 537497###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###BC Cancer - Vancouver Centre###Presenter: – BC Cancer - Vancouver Centre
### 8:10 AM – 8:17 AM PT
214 - Multi-Institutional Validation of the Recursive Partitioning Analysis for Overall Survival in Patients Undergoing Spine Radiosurgery for Spine MetastasisLocation: Room 4Presenter: – University of Iowa Hospitals and Clinics
Sami Koro, MD – University of Iowa Hospitals and Clinics ### 1975152###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Iowa Hospitals and Clinics###Presenter: – University of Iowa Hospitals and Clinics
### 8:20 AM – 8:27 AM PT
215 - Predictors of Hepatotoxicity in Patients with Metastatic Solid Tumors Treated with Immune Checkpoint Inhibition (ICI) and Liver-Directed SBRTLocation: Room 4Presenter: – University of Chicago
Connor Lynch, MD – University of Chicago ### 746582###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Chicago###Presenter: – University of Chicago
### 8:30 AM – 8:37 AM PT
216 - Prompt Pain Relief: Advanced Practice Provider Led Rapid Access Palliative Radiotherapy ClinicLocation: Room 4Presenter: – Mayo Clinic Florida
Michelle Wear, MSN – Mayo Clinic Florida ### 1975154###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mayo Clinic Florida###Presenter: – Mayo Clinic Florida
### 8:40 AM – 8:47 AM PT
217 - Provider Perceptions of a Novel Inpatient Co-Rounding Model Integrating Medical Oncology, Neuro-Oncology, and Radiation Oncology for the Care of Patients with Advanced CancerLocation: Room 4Presenter: – University of California San Francisco
Lisa Ni, MD – University of California San Francisco ### 538130###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California San Francisco###Presenter: – University of California San Francisco
### 8:50 AM – 9:00 AM PT
DiscussantLocation: Room 4Discussant: – Beth Israel Deaconess Medical Center
Lauren Hertan, MD, MS – Beth Israel Deaconess Medical Center ### 746701###Discussant###Disclosures: Employment: Beth Israel Deaconess Medical Center:Physician:Employee;Beth Israel Deaconess Medical Center:Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Beth Israel Deaconess Medical Center###Discussant: – Beth Israel Deaconess Medical Center
### 8:00 AM – 8:07 AM PT
208 - 30 Gy vs. 45 Gy Consolidative Thoracic Radiation (cTRT) for Extensive Stage Small Cell Lung Cancer (ES-SCLC): A Multicenter, Randomized, Phase 3 TrialLocation: Room 6 C/FPresenter: – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Nan Bi, MD, PhD – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College ### 584248###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College###Presenter: – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
### 8:10 AM – 8:17 AM PT
209 - Thoracic Radiotherapy Improves the Outcomes of Extensive Stage Small-Cell Lung Cancer Patients Receiving First-Line Immunotherapy: A Multicenter Retrospective AnalysisLocation: Room 6 C/FPresenter: – Shandong Cancer Hospital and Institute
Linlin Wang, MD, PhD – Shandong Cancer Hospital and Institute ### 1975167###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Cancer Hospital and Institute###Presenter: – Shandong Cancer Hospital and Institute
### 8:20 AM – 8:27 AM PT
210 - A Multicentered, Randomized Phase ? Study of Definitive vs. Palliative Radiotherapy to Primary Tumor for Stage ? Non-Small Cell Lung Cancer with Less than Three Metastatic Organs: CSWOG ChinaLocation: Room 6 C/FPresenter: – The Affiliated Hospital of Guizhou Medical University
Geng Yichao, MD – The Affiliated Hospital of Guizhou Medical University ### 2037789###Presenter###Disclosures: Employment: Affiliated Hospital of Guizhou Medical University:Attending physician:Employee;Affiliated Cancer Hospital of Guizhou Medical University:Attending physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###The Affiliated Hospital of Guizhou Medical University###Presenter: – The Affiliated Hospital of Guizhou Medical University
### 8:30 AM – 8:37 AM PT
211 - Stereotactic Ablative Radiotherapy for Oligo-Progressive Cancers: Results of the Randomized Phase II STOP TrialLocation: Room 6 C/FPresenter: – BC Cancer - Vancouver Centre
Devin Schellenberg, MD, BS – BC Cancer - Vancouver Centre ### 1975169###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###BC Cancer - Vancouver Centre###Presenter: – BC Cancer - Vancouver Centre
### 8:40 AM – 8:45 AM PT
212 - Safety and Efficacy Analysis of Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Treated with SHR-1316 Plus Chemotherapy and Sequential Chest Radiotherapy as First-Line Therapy from a PhLocation: Room 6 C/FPresenter: – Shandong Cancer Hospital and Institute
Linlin Wang, MD, PhD – Shandong Cancer Hospital and Institute ### 1975167###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Cancer Hospital and Institute###Presenter: – Shandong Cancer Hospital and Institute
### 8:48 AM – 8:58 AM PT
DiscussantLocation: Room 6 C/FDiscussant: – Mayo Clinic Rochester
Dawn Owen, MD, PhD – Mayo Clinic Rochester ### 525127###Discussant###Disclosures: Employment: Mayo Clinic:Physician:Employee | Compensation: Astra Zeneca: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present ;Varian: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: present ;UptoDate: Other, Honoraria-End Date: present | Ownership: none | Leadership: none###Mayo Clinic Rochester###Discussant: – Mayo Clinic Rochester
### 8:00 AM – 8:07 AM PT
202 - Multitask AI Models for the Joint Prediction of Overall Survival, Progression-Free Survival, and Death without Progression as a Composite Endpoint for LA-NSCLC Patients Treated with ChemoradiotherapyLocation: Room 2Presenter: – University of Pennsylvania
Sang Ho Lee, PhD – University of Pennsylvania ### 1971988###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pennsylvania###Presenter: – University of Pennsylvania
### 8:10 AM – 8:17 AM PT
203 - Deployment of a Deep Learning Automated Cardiac Sub-Structure Contouring Algorithm to Measure Coronary Dose Exposure Trends in Lung Cancer Radiation TherapyLocation: Room 2Presenter: – Brigham and Womens Hopsital
Christian Guthier, PhD, MS – Brigham and Womens Hopsital ### 536013###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Brigham and Womens Hopsital###Presenter: – Brigham and Womens Hopsital
### 8:20 AM – 8:27 AM PT
204 - Dynamic Prediction of Toxicities in Head and Neck Cancer Radiotherapy by 3D Convolutional Neural Network Using Daily Cone-Beam CTsLocation: Room 2Presenter: – Centre Hospitalier de l'Universite de Montreal (CHUM)
Chulmin Bang, MD – Centre Hospitalier de l'Universite de Montreal (CHUM) ### 1971989###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Centre Hospitalier de l'Universite de Montreal (CHUM)###Presenter: – Centre Hospitalier de l'Universite de Montreal (CHUM)
### 8:30 AM – 8:37 AM PT
205 - Deep Learning for Automatic Prediction of Lymph Node Station Metastasis in Esophageal Cancer Patients from Contrast-Enhanced CTLocation: Room 2Presenter: – Sichuan Cancer Hospital and Institute
Qifeng Wang, MD, PhD – Sichuan Cancer Hospital and Institute ### 2094333###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sichuan Cancer Hospital and Institute###Presenter: – Sichuan Cancer Hospital and Institute
### 8:40 AM – 8:47 AM PT
206 - Machine Parameter Optimization of a Clinical Linear Accelerator Using Deep Reinforcement Learning for Automatic Generation of Deliverable Prostate VMAT PlansLocation: Room 2Presenter: – Johns Hopkins University
William Hrinivich, PhD – Johns Hopkins University ### 748017###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins University###Presenter: – Johns Hopkins University
### 8:50 AM – 8:57 AM PT
207 - Clinico-Genomics Model to Predict Survival in Non-Metastatic Breast Cancer: Comparing the Performance of Machine Learning ModelsLocation: Room 2Presenter: – Rush University Medical Center
Adrianna Cueto-Marquez, MD, BS – Rush University Medical Center ### 1971990###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Rush University Medical Center###Presenter: – Rush University Medical Center
### 8:05 AM – 8:10 AM PT
1278 - Real-Time 3D Liver Tumor Localization via Combined Optical Surface Imaging and an X-Ray Projection from Arbitrary Imaging AnglesLocation: Room 8Presenter: – University of Texas Southwestern Medical Center
Hua-Chieh Shao, PhD – University of Texas Southwestern Medical Center ### 1973155###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Texas Southwestern Medical Center###Presenter: – University of Texas Southwestern Medical Center
### 8:10 AM – 8:15 AM PT
1280 - Development of a Filtimator for Pediatric Image-Guided Radiation Therapy with Low Imaging DoseLocation: Room 8Presenter: – University of Florida Proton Therapy Institute
Soon Huh, PhD – University of Florida Proton Therapy Institute ### 1973027###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Florida Proton Therapy Institute###Presenter: – University of Florida Proton Therapy Institute
### 8:15 AM – 8:20 AM PT
1282 - Real Time 4D-Cone Beam CT via Single-Angle Projection with Dual Attention MechanismLocation: Room 8Presenter: – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Jun Dang, PhD – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center ### 1973156###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center###Presenter: – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
### 8:20 AM – 8:25 AM PT
1284 - SEA-Net: Structure-Enhanced Attention Network for Limited-Angle CBCT Reconstruction of Clinical Projection DataLocation: Room 8Presenter: – University of Kansas Medical Center
Hao Gao, PhD – University of Kansas Medical Center ### 746653###Presenter###Disclosures: Employment: University of Kansas:Associate Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Kansas Medical Center###Presenter: – University of Kansas Medical Center
### 8:25 AM – 8:30 AM PT
1286 - Rapid Unpaired CBCT-based Synthetic CT for CBCT-guided Adaptive RadiotherapyLocation: Room 8Presenter: – Emory University School of Medicine
Jacob Wynne, MD – Emory University School of Medicine ### 537584###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Emory University School of Medicine###Presenter: – Emory University School of Medicine
### 8:30 AM – 8:35 AM PT
1288 - Liver Dome Gating Using kV Triggered Imaging Reduces Dosimetric Error Caused by Breath Hold Variability for Liver Stereotactic Body Radiation TherapyLocation: Room 8Presenter: – Cleveland Clinic Taussig Cancer Center
Bingqi Guo, PhD – Cleveland Clinic Taussig Cancer Center ### 747965###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Taussig Cancer Center###Presenter: – Cleveland Clinic Taussig Cancer Center
### 12:50 PM – 12:55 PM PT
1084 - Bacterial Composition and Diversity in the Cervical Tumor Microbiome are Closely Associated with HPV Genotype in a Large, International Patient CohortLocation: Room 7Presenter: – MD Anderson Cancer Center
Molly El Alam, MPH – MD Anderson Cancer Center ### 1972075###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 12:55 PM – 1:00 PM PT
1086 - Postoperative Radiotherapy to Abdominal and Pelvic Lymphatic Drainage Area for Stage III Epithelial Ovarian Cancer: A Sharp Tool to Prolong Disease-Free Survival TimeLocation: Room 7Presenter: – Chinese Academy of Medical Sciences and Peking Union Medical College
Jing Shen, MD – Chinese Academy of Medical Sciences and Peking Union Medical College ### 1972076###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chinese Academy of Medical Sciences and Peking Union Medical College###Presenter: – Chinese Academy of Medical Sciences and Peking Union Medical College
### 1:00 PM – 1:05 PM PT
1088 - Genomic Characterization of Cervical Tumors Driven by Rare High-Risk HPV Subtypes Utilizing a Deep Learning FrameworkLocation: Room 7Presenter: – Washington University St. Louis
Michael Waters, MD, PhD – Washington University St. Louis ### 535929###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Washington University St. Louis###Presenter: – Washington University St. Louis
### 1:10 PM – 1:15 PM PT
1092 - Machine-Learning Model of Pre-Treatment MRI Accurately Predicts Progression Following Cervical Cancer RadiotherapyLocation: Room 7Presenter: – George Washington University School of Medicine
Jeffrey Wang, BS – George Washington University School of Medicine ### 1972079###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###George Washington University School of Medicine###Presenter: – George Washington University School of Medicine
### 1:15 PM – 1:22 PM PT
1094 - The Prognostic Impact of Substantial Lymphovascular Space Invasion in Women with FIGO Stage I Uterine Endometrioid Carcinoma with Pathologically Negative Nodal EvaluationLocation: Room 7Presenter: – Henry Ford Hospital
Aseem Bhatnagar, MD – Henry Ford Hospital ### 1981332###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Henry Ford Hospital###Presenter: – Henry Ford Hospital
### 12:45 PM – 12:52 PM PT
224 - Intravoxel Incoherent Motion (IVIM) Magnetic Resonance Imaging (MRI) for Assessment of Treatment Response in Unresectable Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)Location: Room 29Presenter: – MD Anderson Cancer Center
Lucas McCullum, BS – MD Anderson Cancer Center ### 2082187###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 12:55 PM – 1:02 PM PT
225 - Differential Response in Quantitative MRI Parameters Detected in Head and Neck Cancer Patients Treated with Concurrent Immunotherapy during Hypo-Fractionated MR-gRTLocation: Room 29Presenter: – Medical College of Wisconsin
Ryan Bonate, BS – Medical College of Wisconsin ### 1975173###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Medical College of Wisconsin###Presenter: – Medical College of Wisconsin
### 1:05 PM – 1:12 PM PT
226 - Pattern Analysis of Daily Lesion Volume Trajectories for Early Prediction of Glioblastoma Progression During MR-Linac RadiotherapyLocation: Room 29Presenter: – University of Miami Sylvester Comprehensive Cancer Center
Kaylie Cullison, BS – University of Miami Sylvester Comprehensive Cancer Center ### 1972082###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Miami Sylvester Comprehensive Cancer Center###Presenter: – University of Miami Sylvester Comprehensive Cancer Center
### 1:15 PM – 1:22 PM PT
227 - Fraction Size, Total Dose and Respiratory Control Impact Local Control in Adrenal SBRTLocation: Room 29Presenter: – Tel Hashomer Hospital
Ory Haisraely, MD, MPH – Tel Hashomer Hospital ### 1975174###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Tel Hashomer Hospital###Presenter: – Tel Hashomer Hospital
### 1:25 PM – 1:32 PM PT
228 - Tumor Voxel Dose-Response Matrix Prediction Using Deep LearningLocation: Room 29Presenter: – Corewell Health William Beaumont University Hospital
Shupeng Chen, PhD – Corewell Health William Beaumont University Hospital ### 1973070###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Corewell Health William Beaumont University Hospital###Presenter: – Corewell Health William Beaumont University Hospital
### 1:35 PM – 1:42 PM PT
229 - Image Derived Estimates of Fibrosis Using Ultrashort Echo Time MRI in Gynecologic CancerLocation: Room 29Presenter: – Johns Hopkins University School of Medicine
Khadija Sheikh, PhD, MS – Johns Hopkins University School of Medicine ### 536006###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins University School of Medicine###Presenter: – Johns Hopkins University School of Medicine
### 1:45 PM – 1:52 PM PT
230 - Comprehensive Quality of Life Report from a Prospective Clinical Trial of 4DCT-Ventilation Functional Lung Avoidance Radiation TherapyLocation: Room 29Presenter: – MD Anderson Cancer Center at Cooper
Joseph Lombardo, DO – MD Anderson Cancer Center at Cooper ### 2027547###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center at Cooper###Presenter: – MD Anderson Cancer Center at Cooper
### 12:45 PM – 12:52 PM PT
218 - Management and Outcomes of Hodgkin Lymphoma Patients Who Achieve Partial Metabolic Response on PET Scans Post-ChemotherapyLocation: Room 1Presenter: – University of Toronto
Donna Liao, MD – University of Toronto ### 1972018###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Toronto###Presenter: – University of Toronto
### 12:55 PM – 1:02 PM PT
219 - Quality Analysis of Radiation Therapy for Hodgkin Lymphoma in the HD 16/17 Trials: A Final Report By the Reference Radiation Oncology Panel of the German Hodgkin Study GroupLocation: Room 1Presenter: – University Hospital of Muenster
Michael Oertel, MD – University Hospital of Muenster ### 1972019###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University Hospital of Muenster###Presenter: – University Hospital of Muenster
### 1:05 PM – 1:12 PM PT
220 - Radiotherapy Utilization and Outcomes on a Contemporary Trial for Pediatric High-Risk Hodgkin Lymphoma StudyLocation: Room 1Presenter: – Mayo Clinic Florida
Bradford Hoppe, MD, FASTRO, MPH – Mayo Clinic Florida ### 535819###Presenter###Disclosures: Employment: Mayo Clinic:Professor of Radiation Oncology:Employee | Compensation: Merck: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Remuneration Other-End Date: Present | Ownership: none | Leadership: PTCOG:Secretary;NRG lymphoma working group:Co-Chair###Mayo Clinic Florida###Presenter: – Mayo Clinic Florida
### 1:15 PM – 1:22 PM PT
221 - Radiotherapy in Young, High-Risk Patients with Aggressive B-cell Lymphoma: Long-Term Results from the Open-Label, Randomized, Phase 3 R-MegaCHOEP TrialLocation: Room 1Presenter: – University Hospital of Muenster
Michael Oertel, MD – University Hospital of Muenster ### 1972019###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University Hospital of Muenster###Presenter: – University Hospital of Muenster
### 1:25 PM – 1:32 PM PT
222 - Association of Overall Survival Benefit Profile of Radiotherapy with Progression-Free Survival after Chemotherapy for Diffuse Large B-Cell LymphomaLocation: Room 1Presenter: – Cancer Hospital Chinese Academy of Medical Sciences
Jingnan Wang, MD – Cancer Hospital Chinese Academy of Medical Sciences ### 1972020###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cancer Hospital Chinese Academy of Medical Sciences###Presenter: – Cancer Hospital Chinese Academy of Medical Sciences
### 1:35 PM – 1:42 PM PT
223 - Radiation Therapy in the Management of Primary Gastric Diffuse Large B-Cell Lymphomas: Long-Term Outcomes of 82 PatientsLocation: Room 1Presenter: – Memorial Sloan Kettering Cancer Center
Beatrice Fregonese, MPH – Memorial Sloan Kettering Cancer Center ### 1972021###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 1:45 PM – 1:55 PM PT
DiscussantLocation: Room 1Discussant: – Stanford University
Richard Hoppe, MD, FASTRO – Stanford University ### 536142###Discussant###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Discussant: – Stanford University
### 12:50 PM – 12:55 PM PT
1096 - Impact of Consolidative Radiation on Overall and Progression Free Survival in Pediatric, Adolescent and Young Adult Metastatic SarcomaLocation: Room 8Presenter: – Johns Hopkins University
Leslie Chang, MD – Johns Hopkins University ### 1972059###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins University###Presenter: – Johns Hopkins University
### 12:55 PM – 1:00 PM PT
1098 - The Role of Whole Abdomen and Pelvis Radiation Therapy in Desmoplastic Small Round Cell TumorLocation: Room 8Presenter: – UNC Hospitals
Michael Young, MD – UNC Hospitals ### 1972060###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UNC Hospitals###Presenter: – UNC Hospitals
### 1:00 PM – 1:05 PM PT
1100 - Association between Radiation Dose and Local Failure in Recurrent High-Risk NeuroblastomaLocation: Room 8Presenter: – MD Anderson Cancer Center
Christopher Weil, MD, MS – MD Anderson Cancer Center ### 535876###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 1:05 PM – 1:10 PM PT
1102 - Proton Therapy Mediates Dose Reductions to Critical Brain Organs-at-Risk which are Associated with Better Cognition in Children with MedulloblastomaLocation: Room 8Presenter: – Juravinski Cancer Centre
Julianna Sienna, MD, MS – Juravinski Cancer Centre ### 747494###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Juravinski Cancer Centre###Presenter: – Juravinski Cancer Centre
### 1:10 PM – 1:15 PM PT
1104 - Memantine for Pediatric Patients Receiving Cranial Irradiation: A Pilot StudyLocation: Room 8Presenter: – Mayo Clinic Rochester
Elizabeth McKone, MD – Mayo Clinic Rochester ### 1972061###Presenter###Disclosures: Employment: Mayo Clinic Rochester:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Mayo Clinic Rochester###Presenter: – Mayo Clinic Rochester
### 1:15 PM – 1:20 PM PT
1106 - Pancreas: An Organ-at-Risk to Consider in Future Pediatric Abdominal RadiotherapyLocation: Room 8Presenter: – University College London
Sabrina Taylor, BS – University College London ### 1972062###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University College London###Presenter: – University College London
### 2:30 PM – 2:37 PM PT
231 - Involved Site Radiotherapy in HPV Positive Oropharyngeal Cancer: Patterns of Failure Analysis Across Prospective De-Escalation TrialsLocation: Room 1Presenter: – University of Chicago Medicine
Zaid Iftekaruddin, MD – University of Chicago Medicine ### 1975164###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Chicago Medicine###Presenter: – University of Chicago Medicine
### 2:40 PM – 2:47 PM PT
232 - A Phase II Trial Evaluating Rapid Mid-Treatment Nodal Shrinkage to Select for Adaptive Deescalation in p16+ Oropharyngeal Cancer Patients Undergoing Definitive ChemoradiationLocation: Room 1Presenter: – NYU Langone Medical Center
Joseph Kim, MD – NYU Langone Medical Center ### 537688###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###NYU Langone Medical Center###Presenter: – NYU Langone Medical Center
### 2:50 PM – 2:57 PM PT
233 - Effectiveness of Cisplatin in P16+ Oropharyngeal Cancer According to Relative Risk for Cancer Events: Ancillary Analysis of RTOG 1016Location: Room 1Presenter: – University of California, San Diego
Loren Mell, MD, FASTRO – University of California, San Diego ### 516064###Presenter######University of California, San Diego###Presenter: – University of California, San Diego
### 2:50 PM – 2:57 PM PT
233 - Effectiveness of Cisplatin in P16+ Oropharyngeal Cancer According to Relative Risk for Cancer Events: Ancillary Analysis of RTOG 1016Location: Room 1Presenter: – University of North Carolina at Chapel Hill
Ryan Morse, MD – University of North Carolina at Chapel Hill ### 537838###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of North Carolina at Chapel Hill###Presenter: – University of North Carolina at Chapel Hill
### 3:00 PM – 3:07 PM PT
234 - Local Cost-Effectiveness of Nasopharyngeal Carcinoma Screening Strategies in Southern China: Secondary Analysis of the PRO-NPC-001 Cluster-Randomized TrialLocation: Room 1Presenter: – Cleveland Clinic Foundation
Jacob Miller, MD – Cleveland Clinic Foundation ### 537835###Presenter###Disclosures: Employment: Cleveland Clinic Foundation:Associate Staff:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Cleveland Clinic Foundation###Presenter: – Cleveland Clinic Foundation
### 3:10 PM – 3:17 PM PT
235 - Prospective Efficacy of Two Cycles Toripalimab Plus Induction Chemotherapy in T4 or N3 Locoregionally Advanced Nasopharyngeal Carcinoma: A Retrospective and Mechanistic StudyLocation: Room 1Presenter: – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Fengming Lan, MD – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center ### 1975165###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center###Presenter: – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
### 3:20 PM – 3:30 PM PT
DiscussantLocation: Room 1Discussant: – Massachusetts General Hospital
Annie Chan, MD – Massachusetts General Hospital ### 525096###Discussant###Disclosures: Employment: MGH:physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Massachusetts General Hospital###Discussant: – Massachusetts General Hospital
### 2:35 PM – 2:40 PM PT
1108 - The Presence of Extensive Lymphovascular Invasion (LVI) is Associated with Higher Risk of Recurrence in Curatively Treated Breast Cancer PatientsLocation: Room 7Presenter: – Philadelphia College of Osteopathic Medicine
Olufela Koleoso, MS, BS – Philadelphia College of Osteopathic Medicine ### 1972088###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Philadelphia College of Osteopathic Medicine###Presenter: – Philadelphia College of Osteopathic Medicine
### 2:40 PM – 2:45 PM PT
1110 - 5-Year Results from a Prospective Phase II Trial of Ten-Fractions Hypofractionated Radiotherapy in Locally Advanced Breast CancerLocation: Room 7Presenter: – Regina Elena National Cancer Institute
Silvia Takanen, MD – Regina Elena National Cancer Institute ### 2057690###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Regina Elena National Cancer Institute###Presenter: – Regina Elena National Cancer Institute
### 2:45 PM – 2:50 PM PT
1112 - Addition of Metastasis-Directed Therapy to Standard of Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase II TrialLocation: Room 7Presenter: – MD Anderson Cancer Center
Jay Paul Reddy, MD, PhD – MD Anderson Cancer Center ### 746706###Presenter###Disclosures: Employment: MD Anderson Cancer Center:Assistant Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 2:50 PM – 2:55 PM PT
1114 - First Results of the Primary Outcome of a Phase II Prospective Clinical Trial to Assess the Feasibility of Preoperative Radiation Boost in Breast Cancer PatientsLocation: Room 7Presenter: – Associates in Radiation Medicine-ARM Oncology
Zeinab Abou Yehia, MD – Associates in Radiation Medicine-ARM Oncology ### 537607###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Associates in Radiation Medicine-ARM Oncology###Presenter: – Associates in Radiation Medicine-ARM Oncology
### 2:55 PM – 3:00 PM PT
1116 - Single-Fraction Pre-Operative Stereotactic Radiosurgery for Early-Stage Breast Cancer: Pathological FindingsLocation: Room 7
Marco Trovo ### 2159044###Presenter#########Presenter:
### 3:00 PM – 3:05 PM PT
1118 - Factors Associated with Cardiac Radiation Dose Reduction Following Hypofractionated Radiation Therapy for Localized, Left-Sided Breast Cancer in a Large Statewide Quality ConsortiumLocation: Room 7Presenter: – University of Michigan
Daniel Herr, MD, PhD – University of Michigan ### 1972091###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Michigan###Presenter: – University of Michigan
### 2:33 PM – 2:40 PM PT
243 - Results of a Phase I Trial of Dose Escalation for Preoperative Stereotactic Radiosurgery for Patients with Large Brain MetastasesLocation: Room 6 C/FPresenter: – Cleveland Clinic Taussig Cancer Center
Kailin Yang, MD, PhD – Cleveland Clinic Taussig Cancer Center ### 746583###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Taussig Cancer Center###Presenter: – Cleveland Clinic Taussig Cancer Center
### 2:43 PM – 2:50 PM PT
244 - Radiotherapy for Metastatic Spinal Cord Compression with Increased Doses: Final Results of the RAMSES-01 TrialLocation: Room 6 C/FPresenter: – University of Luebeck
Dirk Rades, MD, FASTRO – University of Luebeck ### 1974897###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Luebeck###Presenter: – University of Luebeck
### 2:53 PM – 3:00 PM PT
245 - Results of a Multi-institutional Randomized Phase 3 Trial of Parotid-Sparing Whole Brain RadiotherapyLocation: Room 6 C/FPresenter: – University of Cincinnati
Kyle Wang, MD – University of Cincinnati ### 524693###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Cincinnati###Presenter: – University of Cincinnati
### 3:03 PM – 3:10 PM PT
246 - Evidence-Based Multivariate Normal Tissue Complication Probability (NTCP) Study of Domain-Specific Cognitive Decline after Partial Brain RTLocation: Room 6 C/FPresenter: – UCSD Radiation Medicine and Applied Sciences
Austin Hopper, MD – UCSD Radiation Medicine and Applied Sciences ### 747811###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UCSD Radiation Medicine and Applied Sciences###Presenter: – UCSD Radiation Medicine and Applied Sciences
### 3:13 PM – 3:20 PM PT
247 - Genomic Predictors of Leptomeningeal Disease Development among Patients with Brain MetastasesLocation: Room 6 C/FPresenter: – Harvard Radiation Oncology Program
Nayan Lamba, MD – Harvard Radiation Oncology Program ### 537685###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Harvard Radiation Oncology Program###Presenter: – Harvard Radiation Oncology Program
### 3:23 PM – 3:28 PM PT
1262 - Stereotactic Radiotherapy or Whole Brain Radiotherapy Combined with Pyrotinib and Capecitabine in HER2-Positive Advanced Breast Cancer Patients with Brain Metastases (BROPTIMA): A Prospective, Phase ILocation: Room 6 C/FPresenter: – Fudan University Shanghai Cancer Center
Wei Shi, MD, PhD – Fudan University Shanghai Cancer Center ### 1972364###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Fudan University Shanghai Cancer Center###Presenter: – Fudan University Shanghai Cancer Center
### 3:28 PM – 3:38 PM PT
DiscussantLocation: Room 6 C/FDiscussant: – Levine Cancer Institute
Stuart Burri, MD – Levine Cancer Institute ### 535892###Discussant###Disclosures: Employment: Southeast Radiation Oncology Group:President and Partner:Partner | Compensation: Novocure: Other, Travel Expenses, Compensation Payment-End Date: present | Ownership: Southeast Radiation Oncology Group:Partnership;Radiation Oncology Centers of the Carolinas:Ownership Equity;Charlotte Physics Holding:Ownership Equity;FUSE Oncology Holding:Ownership Equity;Oncology Practice Solutions:Ownership Equity | Leadership: Atrium Health - Levine Cancer Institute:Chairman of Radiation Oncology###Levine Cancer Institute###Discussant: – Levine Cancer Institute
### 2:30 PM – 2:37 PM PT
236 - Neoantigen Cancer Vaccine Improves the Therapeutic Efficacy of Radiotherapy in Immunologically Cold Microsatellite-Stable Colorectal CancerLocation: Room 2Presenter: – China Medical University Hospital
K. S. Clifford Chao, MD – China Medical University Hospital ### 2010449###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###China Medical University Hospital###Presenter: – China Medical University Hospital
### 2:40 PM – 2:47 PM PT
237 - Non-Redundant Mechanisms of Immune Resistance to Radiotherapy Converge on Innate ImmunityLocation: Room 2Presenter: – Cedars-Sinai Medical Center
Anthony Nguyen, MD, PhD – Cedars-Sinai Medical Center ### 747824###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cedars-Sinai Medical Center###Presenter: – Cedars-Sinai Medical Center
### 2:50 PM – 2:57 PM PT
238 - The Effect of PARP Inhibitor Radiosensitization on the mRNA Translational Regulation of T Cell ChemokinesPresenter: – University Health Network
Xiaozhuo Ran, PhD – University Health Network ### 1972003###Presenter######University Health Network###Presenter: – University Health Network
### 2:50 PM – 2:57 PM PT
238 - The Effect of PARP Inhibitor Radiosensitization on the mRNA Translational Regulation of T Cell ChemokinesLocation: Room 2Presenter: – Princess Margaret Cancer Centre
Benjamin Lok, MD – Princess Margaret Cancer Centre ### 524997###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Princess Margaret Cancer Centre###Presenter: – Princess Margaret Cancer Centre
### 3:00 PM – 3:07 PM PT
239 - Radiotherapy Shows Synergistic Anti-Tumor Efficacy with Treg Depletion by Reprogramming the Immune-Excluded Tumor MicroenvironmentLocation: Room 2Presenter: – Varian Medical Systems, A Siemens Healthineers Company
Sophia Pfister, PhD – Varian Medical Systems, A Siemens Healthineers Company ### 2029569###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Varian Medical Systems, A Siemens Healthineers Company###Presenter: – Varian Medical Systems, A Siemens Healthineers Company
### 3:10 PM – 3:17 PM PT
240 - Blocking ILT4 Overcomes Radio-Immunotherapy Treatment Resistance by Reversing HFRT Induced CXCL1-CXCR2 Axis Activation and Tumor-Associated Macrophages ImmunosuppressionLocation: Room 2
Xiaozheng Chen, PhD ### 1972005###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 3:30 PM – 3:40 PM PT
DiscussantLocation: Room 2Discussant: – University of Wisconsin Hospitals and Clinics
Zachary Morris, MD, PhD – University of Wisconsin Hospitals and Clinics ### 524492###Discussant###Disclosures: Employment: University of Wisconsin-Madison:Associate Professor:Employee | Compensation: Archeus Technologies: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: Present ;Seneca Therapeutics: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: Present | Ownership: Wisconsin Alumni Research Foundation:Copyright;Archeus Technologies:Stock Options;Seneca Therapeutics:Stock Options | Leadership: none###University of Wisconsin Hospitals and Clinics###Discussant: – University of Wisconsin Hospitals and Clinics
### 2:30 PM – 3:45 PM PT
2972 - Diagnostic Performance of 18F-rhPSMA-7.3 PET in Men with Newly Diagnosed High-Risk Prostate Cancer and Negative Conventional ImagingLocation: Hall B1
Gary Ulaner, MD, PhD ### 1972660###Presenter#########Presenter:
### 2:30 PM – 2:40 PM PT
LBA 08 - Acute Toxicity and Efficiency Outcomes in the DARTBOARD Randomized Trial of Daily Adaptive Radiotherapy for Head and Neck Squamous Cell CarcinomaLocation: Room 6 BPresenter: – University of Texas Southwestern Medical Center
David Sher, MD, MPH – University of Texas Southwestern Medical Center ### 516014###Presenter###Disclosures: Employment: University of Texas Southwestern Medical Center:Professor:Employee | Compensation: Varian Medical Center: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 03/01/2024 | Ownership: none | Leadership: none###University of Texas Southwestern Medical Center###Presenter: – University of Texas Southwestern Medical Center
### 2:40 PM – 2:50 PM PT
LBA 09 - Stereotactic Ablative Body Radiotherapy (SABR) for Oligoprogressive ER-Positive Breast Cancer (AVATAR): A Phase II Prospective Multicenter TrialLocation: Room 6 BPresenter: – Peter MacCallum Cancer Centre
Steven David, MD, MBBS – Peter MacCallum Cancer Centre ### 2105489###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Peter MacCallum Cancer Centre###Presenter: – Peter MacCallum Cancer Centre
### 2:50 PM – 3:00 PM PT
LBA 10 - Partial Breast Radiotherapy for Women with Early Breast Cancer: 10-Year Outcomes from IMPORT LOW (CRUK/06/003)Location: Room 6 BPresenter: – Royal Marsden NHS Foundation Trust
Anna Kirby, MD – Royal Marsden NHS Foundation Trust ### 1974947###Presenter###Disclosures: Employment: Royal Marsden/ Institute of Cancer Research:Consultant Oncologist:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: European Society of Radiotherapy and Oncology:President 2022-24###Royal Marsden NHS Foundation Trust###Presenter: – Royal Marsden NHS Foundation Trust
### 3:00 PM – 3:10 PM PT
LBA 11 - Early Results of a Phase I Pre-Operative Single Fraction Ablative Trial for Early Stage Breast CancerLocation: Room 6 BPresenter: – University of Texas Southwestern Medical Center
Asal Rahimi, MD, MS – University of Texas Southwestern Medical Center ### 524517###Presenter###Disclosures: Employment: University Texas Southwestern Medical School:Associate Professor:Employee | Compensation: Accuray: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Education Meeting Faculty, Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Honoraria, Travel Expenses-End Date: present ;GE Health: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: 2022 ;Hologic: Consultant, Education Meeting Faculty, Honoraria, Compensation Payment-End Date: 2022 | Ownership: none | Leadership: NCCN:Breast Cancer Risk Reduction Panel###University of Texas Southwestern Medical Center###Presenter: – University of Texas Southwestern Medical Center
### 3:10 PM – 3:20 PM PT
LBA 12 - Stereotactic Radiosurgery for 1-10 Brain Metastases avoids Whole-Brain Radiotherapy - Results of the CYBER-SPACE Randomized Phase 2 TrialLocation: Room 6 BPresenter: – University Medical Center Gottingen (UMG)
Rami El Shafie, MD – University Medical Center Gottingen (UMG) ### 2105490###Presenter######University Medical Center Gottingen (UMG)###Presenter: – University Medical Center Gottingen (UMG)
### 3:20 PM – 3:30 PM PT
LBA 13 - Hypofractionated Stereotactic Radiotherapy (HFSRT) of the Resection Cavity versus Whole-Brain Radiotherapy (WBRT) following Brain Metastasis Resection - Results of the ESTRON Randomized Phase 2 TrialLocation: Room 6 BPresenter: – University Medical Center Gottingen (UMG)
Rami El Shafie, MD – University Medical Center Gottingen (UMG) ### 2105490###Presenter######University Medical Center Gottingen (UMG)###Presenter: – University Medical Center Gottingen (UMG)
### 3:30 PM – 3:40 PM PT
LBA 14 - Diagnostic CT-Enabled Radiation Therapy (DART): Results of a Randomized Trial for Palliative Radiation TherapyLocation: Room 6 BPresenter: – London Regional Cancer Program
Melissa O'Neil, MRT(T) – London Regional Cancer Program ### 2082172###Presenter###Disclosures: Employment: London Regional Cancer Program:Clinical Specialist Radiation Therapist:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###London Regional Cancer Program###Presenter: – London Regional Cancer Program
### 4:00 PM – 4:07 PM PT
248 - Outcomes Following Radiation Therapy (RT) for Very Young Age CNS Embryonal Tumors on COG ACNS0334 According to Molecular-Confirmed DiagnosisLocation: Room 2Presenter: – SUNY Upstate Radiation Oncology
Katherine Schumacher, MD – SUNY Upstate Radiation Oncology ### 1972008###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###SUNY Upstate Radiation Oncology###Presenter: – SUNY Upstate Radiation Oncology
### 4:10 PM – 4:17 PM PT
249 - Long Term Clinical Outcome and Quality of Life of Children, Adolescents and Young Adults Treated with Pencil Beam Scanning Proton Therapy for RhabdomyosarcomaLocation: Room 2Presenter: – Paul Scherrer Institute
Dominic Leiser, MD – Paul Scherrer Institute ### 1972009###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Paul Scherrer Institute###Presenter: – Paul Scherrer Institute
### 4:20 PM – 4:27 PM PT
250 - High-Dose-Rate Brachytherapy for Vaginal Rhabdomyosarcoma (RMS): Lessons Learned at a Single InstitutionLocation: Room 2Presenter: – Memorial Sloan Kettering Cancer Center
Kaitlyn Lapen, MD – Memorial Sloan Kettering Cancer Center ### 747748###Presenter###Disclosures: Employment: Memorial Sloan Kettering Cancer Center:Resident:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 4:30 PM – 4:37 PM PT
251 - Dose-Effect of Proton and Photon Craniospinal Irradiation on Vertebral Growth in Pediatric Patients with MedulloblastomaLocation: Room 2Presenter: – St. Jude Children's Research Hospital
Carol Oliveira, MD, PhD – St. Jude Children's Research Hospital ### 747246###Presenter######St. Jude Children's Research Hospital###Presenter: – St. Jude Children's Research Hospital
### 4:40 PM – 4:47 PM PT
252 - Intraoperative Radiation Therapy for Pediatric Patients: A 25 Year ExperienceLocation: Room 2Presenter: – University of Miami Miller School of Medicine
Brianna Conte, BS – University of Miami Miller School of Medicine ### 1972010###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Miami Miller School of Medicine###Presenter: – University of Miami Miller School of Medicine
### 4:50 PM – 5:00 PM PT
DiscussantLocation: Room 2Discussant: – Stanford University
Susan Hiniker, MD – Stanford University ### 525198###Discussant###Disclosures: Employment: Stanford University:Assistant Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Stanford University###Discussant: – Stanford University
### 4:05 PM – 4:10 PM PT
1132 - Proton Single-Energy Bragg-Peak FLASH Using Clinical Systems Can Achieve IMPT-Equivalent Plan Quality for Breast and Prostate CancersLocation: Room 7Presenter: – Hofstra University
Tyler Kaulfers, BS – Hofstra University ### 2123548###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Hofstra University###Presenter: – Hofstra University
### 4:10 PM – 4:15 PM PT
1134 - Initial Experience with the Commercial Electron FLASH Research ExtensionLocation: Room 7Presenter: – University of Nebraska Medical Center
Kyle Gallagher, PhD – University of Nebraska Medical Center ### 1972050###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Nebraska Medical Center###Presenter: – University of Nebraska Medical Center
### 4:15 PM – 4:20 PM PT
1136 - 3D Dosimetry for Electron Flash Radiotherapy: Assessment of Radiochromic Dosimeter Phantoms with Optical CT Scanning as a 3D Dosimetry SystemLocation: Room 7Presenter: – Columbia University Irving Medical Center
Carl Elliston, MS, DABR – Columbia University Irving Medical Center ### 1972051###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Columbia University Irving Medical Center###Presenter: – Columbia University Irving Medical Center
### 4:20 PM – 4:25 PM PT
1138 - Proton LET Optimization Via Iterative Convex Relaxation MethodLocation: Room 7Presenter: – University of Kansas Medical Center
Wangyao Li, PhD – University of Kansas Medical Center ### 1972052###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Kansas Medical Center###Presenter: – University of Kansas Medical Center
### 4:25 PM – 4:30 PM PT
1140 - Clinical Characterization of a Novel Robotic IORT UnitLocation: Room 7Presenter: – Stanford Advanced Medicine Center
Thomas Niedermayer, PhD – Stanford Advanced Medicine Center ### 1972053###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford Advanced Medicine Center###Presenter: – Stanford Advanced Medicine Center
### 4:30 PM – 4:35 PM PT
1142 - Efficacy of Curvilinear Needle Implantation for Prostate HDR BrachytherapyLocation: Room 7Presenter: – University of Florida
Rihan Podder, BS – University of Florida ### 1972054###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Florida###Presenter: – University of Florida
### 4:05 PM – 4:10 PM PT
1120 - Sema3C Signaling is an Alternative Activator of the Canonical WNT Pathway in GlioblastomaLocation: Room 8Presenter: – Cleveland Clinic Taussig Cancer Center
Jennifer Yu, MD, PhD – Cleveland Clinic Taussig Cancer Center ### 524586###Presenter###Disclosures: Employment: Cleveland Clinic:Staff:Employee | Compensation: NIH: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present ;Cleveland Clinic: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present ;Case Comprehensive Cancer Center: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: to present | Ownership: Abbvie:Stock;Medtronics:Stock | Leadership: International Journal of Hyperthermia:Associate Editor;Molecular Carcinogenesis:Associate Editor;Frontiers in Oncology:Associate Editor###Cleveland Clinic Taussig Cancer Center###Presenter: – Cleveland Clinic Taussig Cancer Center
### 4:10 PM – 4:15 PM PT
1122 - Tumor Resistance to Fractionated Radiotherapy in Obese MiceLocation: Room 8Presenter: – University of California, Davis
Logan Vick, BA – University of California, Davis ### 1975186###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California, Davis###Presenter: – University of California, Davis
### 4:15 PM – 4:20 PM PT
1124 - IKBKE Promotes Radioresistance of Glioblastoma through AKT/FOXO3a PathwayLocation: Room 8
Jie Lu, PhD ### 1975187###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none######Presenter:
### 4:20 PM – 4:25 PM PT
1126 - RAP80 Phase Separation at DNA Double-Strand Break Promotes BRCA1 Recruitment and Tumor Radio-ResistanceLocation: Room 8Presenter: – Sixth Affiliated Hospital, Sun Yat-sen University
Xinjuan Fan, MD, PhD – Sixth Affiliated Hospital, Sun Yat-sen University ### 1975188###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sixth Affiliated Hospital, Sun Yat-sen University###Presenter: – Sixth Affiliated Hospital, Sun Yat-sen University
### 4:25 PM – 4:30 PM PT
1128 - Mitotic Errors Increase Radiation Sensitivity in Multiple Cancer Cell Types and in Laryngeal Cancer PatientsLocation: Room 8Presenter: – University of Wisconsin
Pippa Cosper, MD, PhD – University of Wisconsin ### 525164###Presenter###Disclosures: Employment: University of Wisconsin-Madison:Assistant Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Wisconsin###Presenter: – University of Wisconsin
### 4:30 PM – 4:35 PM PT
1130 - Novel Role of Glycogen Synthase Kinase-3ß in Determining Cancer Cell Response to Genotoxic Stress through Regulation of 53BP1 FunctionLocation: Room 8Presenter: – Duke University
Scarlett Acklin, MD – Duke University ### 746682###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Duke University###Presenter: – Duke University
### 4:05 PM – 4:10 PM PT
1144 - Leveraging a Real-Time Machine Learning Platform to Personalize Quality Assurance at a Large Multi-Site Oncology PracticeLocation: Room 4Presenter: – Oncora Medical LLC
William Lindsay, MD, PhD – Oncora Medical LLC ### 1972092###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Oncora Medical LLC###Presenter: – Oncora Medical LLC
### 4:10 PM – 4:15 PM PT
1146 - Natural Language Processing Identification of Symptoms in Emergency Department Visits in Patients Receiving RadiationLocation: Room 4Presenter: – University of California San Francisco
Alexander Qian, MD – University of California San Francisco ### 2074982###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of California San Francisco###Presenter: – University of California San Francisco
### 4:15 PM – 4:20 PM PT
1148 - Clinical Usability-Oriented Automatic Contour Quality Evaluation for Deep Learning Auto-SegmentationLocation: Room 4Presenter: – Medical College of Wisconsin
Ying Zhang, PhD – Medical College of Wisconsin ### 536015###Presenter###Disclosures: Employment: Medical College of Wisconsin:Clinical Medical Physicist/Instructor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Medical College of Wisconsin###Presenter: – Medical College of Wisconsin
### 4:20 PM – 4:25 PM PT
1150 - Mitigation of IMRT/SBRT Treatment Planning Errors on the First Biology-Guided Radiotherapy System Using FMEA within Six Sigma FrameworkLocation: Room 4Presenter: – University of Alabama at Birmingham
Eric Simiele, PhD – University of Alabama at Birmingham ### 1972094###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Alabama at Birmingham###Presenter: – University of Alabama at Birmingham
### 4:25 PM – 4:30 PM PT
1152 - Quality and Safety Considerations in Image Guided Radiation Therapy: An ASTRO Safety White Paper UpdateLocation: Room 4
Terence Sio, MD, MS – Mayo Clinic ### 535761###Presenter###Disclosures: Employment: Mayo Clinic Arizona:Radiation Oncologist:Employee | Compensation: Catalyst Pharmaceuticals, Inc.: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: 12/31/2022 ;Galera Therapeutics: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: 12/31/2022 ;Novocure, Inc.: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Speaker's Bureau, Honoraria, Travel Expenses-End Date: 12/31/2022 | Ownership: none | Leadership: none###Mayo Clinic###Presenter: – Mayo Clinic
### 4:30 PM – 4:35 PM PT
1154 - Assessing the Sustainability of Initiatives Aimed to Enhance Patient Safety Culture: A > 10-year Experience with Multifaceted InterventionsLocation: Room 4Presenter: – UNC School of Medicine
Ashley Weiner, MD, PhD – UNC School of Medicine ### 1972710###Presenter###Disclosures: Employment: University of North Carolina:Assistant Professor:Employee | Compensation: EmpNia: Advisory Board, Advisory Board Type, Advisory Board Proprietary-End Date: present ;Varian: Consultant-End Date: present | Ownership: none | Leadership: none###UNC School of Medicine###Presenter: – UNC School of Medicine
### 4:05 PM – 4:10 PM PT
1156 - Meta-Analysis of Five Fraction Preoperative Radiotherapy for Soft Tissue SarcomaLocation: Room 5Presenter: – Cleveland Clinic Foundation
Zachary Mayo, MD – Cleveland Clinic Foundation ### 1972095###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Cleveland Clinic Foundation###Presenter: – Cleveland Clinic Foundation
### 4:10 PM – 4:15 PM PT
1158 - Initial Results of a Phase II Trial of Hypofractionated Radiation Therapy for Inoperable Soft Tissue SarcomaLocation: Room 5Presenter: – University of Wisconsin Hospitals and Clinics
Bradley Eckelmann, MD, PhD – University of Wisconsin Hospitals and Clinics ### 1972096###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Wisconsin Hospitals and Clinics###Presenter: – University of Wisconsin Hospitals and Clinics
### 4:15 PM – 4:20 PM PT
1160 - Hypofractionated Accelerated Radiation Dose-Painting (HARD) Improves Local Control in Unresected Soft-Tissue SarcomaLocation: Room 5Presenter: – Moffitt Cancer Center
John Michael Bryant, MD – Moffitt Cancer Center ### 1972097###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Moffitt Cancer Center###Presenter: – Moffitt Cancer Center
### 4:20 PM – 4:25 PM PT
1162 - Pre-Operative Radiotherapy in STS: Does Downsizing Matter?Location: Room 5Presenter: – Medical College of Wisconsin Froedtert Hospital
Paulina Gutkin, BS – Medical College of Wisconsin Froedtert Hospital ### 747121###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Medical College of Wisconsin Froedtert Hospital###Presenter: – Medical College of Wisconsin Froedtert Hospital
### 4:25 PM – 4:30 PM PT
1164 - Dawn of Staging for Head and Neck Soft Tissue Sarcoma: Validation of the Novel 8th Edition AJCC T Classification and Proposed Stage GroupingsLocation: Room 5Presenter: – Princess Margaret Cancer Center, University Health Network
Rohan Salunkhe, MD, MBBS – Princess Margaret Cancer Center, University Health Network ### 747578###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Princess Margaret Cancer Center, University Health Network###Presenter: – Princess Margaret Cancer Center, University Health Network
### 4:30 PM – 4:35 PM PT
1166 - Outcomes for Patients with Head and Neck Sarcoma Treated Curatively with Radiation Therapy and SurgeryLocation: Room 5Presenter: – MD Anderson Cancer Center
Alison Yoder, MD, MPH – MD Anderson Cancer Center ### 535882###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###Presenter: – MD Anderson Cancer Center
### 4:35 PM – 4:40 PM PT
1168 - Patterns of local recurrence and risk of skin recurrence in soft tissue sarcomas after surgical resection.Location: Room 5Presenter: – Stanford University
Agnes Ewongwo, MD – Stanford University ### 1972098###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford University###Presenter: – Stanford University
### 4:00 PM – 5:00 PM PT
Hypofractionated Radiotherapy for Hematological Malignancies during COVID-19 Pandemic and BeyondPresenter: – Amala Institute of Medical Sciences, Thrissur
Febin Antony, MD, MBBS – Amala Institute of Medical Sciences, Thrissur ### 1972745###Presenter######Amala Institute of Medical Sciences, Thrissur###Presenter: – Amala Institute of Medical Sciences, Thrissur
### 4:00 PM – 5:00 PM PT
2992 - Development of Population-Based Pediatric Computational Phantoms for Radiotherapy ApplicationsLocation: Hall B1Presenter: – University College London
Reem Ahmad, PhD – University College London ### 1972760###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University College London###Presenter: – University College London
### 5:15 PM – 5:22 PM PT
259 - FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy (SRT) and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate/Prednisone (AAP) and Apalutamide (Location: Room 6 BPresenter: – Brigham and Women's Hospital/Dana-Farber
Paul Nguyen, MD, FASTRO – Brigham and Women's Hospital/Dana-Farber ### 525077###Presenter###Disclosures: Employment: Brigham and Womens:Physician:Employee | Compensation: Blue Earth: Consultant-End Date: 12/16/21 ;Janssen: Consultant, Grant Research Funding, Honoraria-End Date: Present ;Boston Scientific: Consultant, Honoraria-End Date: Present ;Bayer: Consultant, Honoraria-End Date: 11/1/22 ;Novartis: Consultant, Honoraria-End Date: 12/5/22 ;Nanocan: Consultant, Honoraria-End Date: Present ;Astellas: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present | Ownership: Nanocan:Ownership Equity;Telerad Oncology:Ownership Equity | Leadership: none###Brigham and Women's Hospital/Dana-Farber###Presenter: – Brigham and Women's Hospital/Dana-Farber
### 5:25 PM – 5:32 PM PT
260 - Final Results from a Prospective Randomized Pilot Trial of Stereotactic Body Radiation Therapy vs. Radiofrequency Ablation for the Management of Small Renal Masses (RADSTER)Location: Room 6 BPresenter: – Juravinski Cancer Centre
Anand Swaminath, MD – Juravinski Cancer Centre ### 535861###Presenter###Disclosures: Employment: Anand Swaminath Medicine Professional Corporation:Radiation Oncologist:Employee | Compensation: Astrazeneca: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Education Meeting Faculty, Honoraria-End Date: present ;Eisai: Education Meeting Faculty, Honoraria-End Date: Mar 2021 ;Roche: Research Grants, Research Funding, Research Salary Support,Research Role Description Topic-End Date: present ;Bristol-Myers Squibb: Education Meeting Faculty, Honoraria-End Date: Nov 2022 | Ownership: none | Leadership: none###Juravinski Cancer Centre###Presenter: – Juravinski Cancer Centre
### 5:35 PM – 5:42 PM PT
261 - Impact of Testosterone Recovery on Clinical Outcomes of Patients Treated with Salvage Radiotherapy and Androgen Suppression: A Secondary Analysis of the NRG/RTOG 0534 Spport Phase 3 TrialLocation: Room 6 BPresenter: – University of Miami - Sylvester Cancer Center
Alan Dal Pra, MD – University of Miami - Sylvester Cancer Center ### 536090###Presenter###Disclosures: Employment: University of Miami:Associate Professor and Medical Director:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Miami - Sylvester Cancer Center###Presenter: – University of Miami - Sylvester Cancer Center
### 5:45 PM – 5:52 PM PT
262 - Post-Prostatectomy Risk Stratification of Biochemical Recurrence Using Transfer Learning-Based Multi-Modal Artificial IntelligenceLocation: Room 6 BPresenter: – Case Western Reserve University
Atallah Baydoun, MD, PhD – Case Western Reserve University ### 1972007###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Case Western Reserve University###Presenter: – Case Western Reserve University
### 5:55 PM – 6:02 PM PT
263 - 5-Year Renal Function Outcomes after SABR for Primary Renal Cell Carcinoma: A Report from the International Radiosurgery Oncology Consortium of the Kidney (IROCK)Location: Room 6 BPresenter: – London Health Sciences Centre
Vivian Tan, MD – London Health Sciences Centre ### 1972041###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###London Health Sciences Centre###Presenter: – London Health Sciences Centre
### 6:05 PM – 6:15 PM PT
DiscussantLocation: Room 6 BDiscussant: – Medical College of Wisconsin (MCW)
William Hall, MD – Medical College of Wisconsin (MCW) ### 525191###Discussant###Disclosures: Employment: Medical College of Wisconsin:Associate Professor:Employee | Compensation: Aktis Oncology: Consultant, Compensation Payment-End Date: Present ;Elekta AB, Stockholm, Sweden: Research Grants, Research Funding, Research Salary Support, Grant Research Funding, Travel Expenses-End Date: Present | Ownership: none | Leadership: none###Medical College of Wisconsin (MCW)###Discussant: – Medical College of Wisconsin (MCW)
### 5:15 PM – 5:22 PM PT
253 - Impact of War on Radiotherapy in UkraineLocation: Room 2Presenter: – Stanford Cancer Institute Palo Alto
Yuliia Lozko, MD – Stanford Cancer Institute Palo Alto ### 1972032###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Stanford Cancer Institute Palo Alto###Presenter: – Stanford Cancer Institute Palo Alto
### 5:25 PM – 5:32 PM PT
254 - Radiotherapy Resources in Latin America and the Caribbean: An International Atomic Energy Agency Analysis of Current and Projected NeedsLocation: Room 2Presenter: – Indiana University
May Elbanna, MD, PhD – Indiana University ### 1971540###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Indiana University###Presenter: – Indiana University
### 5:35 PM – 5:42 PM PT
255 - Timely Access to Oncological Treatment in Brazil: Analysis of the 60-Law Compliance in a State DatabaseLocation: Room 2Presenter: – Johns Hopkins School of Public Health
Cecília de Sousa, MD – Johns Hopkins School of Public Health ### 1972033###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins School of Public Health###Presenter: – Johns Hopkins School of Public Health
### 5:45 PM – 5:52 PM PT
256 - Impact of AI-Based Auto-Segmentation on Radiotherapy Processes in Low and Middle-Income CountriesLocation: Room 2Presenter: – Uganda Cancer Institute
Solomon Kibudde, MBBS – Uganda Cancer Institute ### 1972034###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Uganda Cancer Institute###Presenter: – Uganda Cancer Institute
### 5:55 PM – 6:02 PM PT
257 - SCCAg as a Biomarker of Advanced Stage and OS in Limited Resource Setting for Cervical CancerLocation: Room 2Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
Rohini Bhatia, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center ### 538056###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Johns Hopkins Radiation Oncology Kimmel Cancer Center###Presenter: – Johns Hopkins Radiation Oncology Kimmel Cancer Center
### 6:05 PM – 6:12 PM PT
258 - Cobalt Compensator-Based IMRT for Gynecologic Cancer Treatment in Low- and Middle-Income Countries: Equivalence to LINAC-Based IMRTLocation: Room 2Presenter: – University of Washington
Peter Zaki, MD – University of Washington ### 1972035###Presenter###Disclosures: Employment: University of Washington:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Washington###Presenter: – University of Washington
### 5:20 PM – 5:25 PM PT
1194 - Influence of Radiation Fractionation on Immune Repertoire Diversity in Solid Tumor PatientsLocation: Room 8Presenter: – University of Pittsburgh Medical Center
Susannah Ellsworth, MD – University of Pittsburgh Medical Center ### 525331###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Pittsburgh Medical Center###Presenter: – University of Pittsburgh Medical Center
### 5:25 PM – 5:30 PM PT
1196 - Single-Cell and Spatial Transcriptomics Revealing the Role of IDO1 in HPV+ Cervical Cancer Tumor Immune Microenvironment and Its Implications in Radiotherapy and ImmunotherapyLocation: Room 8Presenter: – The University of Hong Kong
Zheng Danyang, MD, PhD, MS – The University of Hong Kong ### 1972071###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###The University of Hong Kong###Presenter: – The University of Hong Kong
### 5:35 PM – 5:40 PM PT
1200 - Characterization of Peripheral T-Cell Dynamics in the Patients with Bone Metastasis from Breast Cancer Following Stereotactic Body RadiotherapyLocation: Room 8Presenter: – Seoul National University
In Ah Kim, MD, PhD – Seoul National University ### 535890###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Seoul National University###Presenter: – Seoul National University
### 5:40 PM – 5:45 PM PT
1202 - PARP Inhibitor Plus Radiotherapy Reshapes IDH1 Mutation Tumor Immune Suppression Microenvironment Potentiating the Efficiency of Immune Checkpoint InhibitorLocation: Room 8Presenter: – Shandong Cancer Hospital and Institute
Xiaoyu Hu, MD, PhD – Shandong Cancer Hospital and Institute ### 1972073###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Cancer Hospital and Institute###Presenter: – Shandong Cancer Hospital and Institute
### 5:45 PM – 5:50 PM PT
1204 - Loss of MAPKAPK2 Enhances cGAS-STING-IFNß1 Pathway Activation in Head and Neck Squamous Cell CarcinomaLocation: Room 8
Deri Morgan, PhD – KUMC ### 1972074###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###KUMC###Presenter: – KUMC
### 5:20 PM – 5:25 PM PT
1182 - Automatic Prediction of Metastasis-Free Survival (MFS) Using Prostate-Specific Membrane Antigen (PSMA) PET for Oligometastatic Castration-Sensitive Prostate Cancer (omCSPC)Location: Room 7Presenter: – University of Maryland Central Maryland Radiation Oncology
Yufeng Cao, PhD – University of Maryland Central Maryland Radiation Oncology ### 1972080###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Maryland Central Maryland Radiation Oncology###Presenter: – University of Maryland Central Maryland Radiation Oncology
### 5:25 PM – 5:30 PM PT
1184 - A Dosimetric Study Indicates the Spinal Cord Irradiation Contributes to Acute Hematologic Toxicities in Non-Small Cell Lung Cancer Patients Receiving Radiotherapy Combined with ImmunotherapyLocation: Room 7Presenter: – Shandong Cancer Hospital and Institute
Jiachun Ma – Shandong Cancer Hospital and Institute ### 1972081###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Shandong Cancer Hospital and Institute###Presenter: – Shandong Cancer Hospital and Institute
### 5:30 PM – 5:35 PM PT
1186 - Novel Functional Radiomics for Prediction of Cardiac PET Avidity in Lung Cancer RadiotherapyLocation: Room 7Presenter: – Thomas Jefferson University
Wookjin Choi, PhD – Thomas Jefferson University ### 525117###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Thomas Jefferson University###Presenter: – Thomas Jefferson University
### 5:35 PM – 5:40 PM PT
1188 - Prognostic Value of Weekly Delta-Radiomics during MR-Linac Radiotherapy of GlioblastomaLocation: Room 7Presenter: – University of Miami Sylvester Comprehensive Cancer Center
Kaylie Cullison, BS – University of Miami Sylvester Comprehensive Cancer Center ### 1972082###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Miami Sylvester Comprehensive Cancer Center###Presenter: – University of Miami Sylvester Comprehensive Cancer Center
### 5:40 PM – 5:45 PM PT
1190 - A Radiogenomic Machine Learning Model for Glioblastoma Post-Resection Overall Survival Group PredictionLocation: Room 7Presenter: – Duke University
Lana Wang, MS – Duke University ### 1972083###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Duke University###Presenter: – Duke University
### 5:45 PM – 5:50 PM PT
1192 - Prediction of Anatomical Presentation during Radiotherapy of Nasopharyngeal Carcinoma Using GAN-LSTM for Plan Adaption DecisionLocation: Room 7Presenter: – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy
Bining Yang, PhD – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy ### 1972084###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy###Presenter: – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy
### 5:20 PM – 5:25 PM PT
1170 - Definitive Chemoradiation Treatment Response Evaluation Using NI-RADS and ctHPVDNA for HPV-Associated Oropharyngeal Squamous Cell CarcinomaLocation: Room 4Presenter: – University of North Carolina at Chapel Hill
Ryan Morse, MD – University of North Carolina at Chapel Hill ### 537838###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of North Carolina at Chapel Hill###Presenter: – University of North Carolina at Chapel Hill
### 5:25 PM – 5:30 PM PT
1172 - The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngeal Cancer in NRG/RTOG 1016Location: Room 4Presenter: – UCLA Radiation Oncology
Joanne Weidhaas, MD, PhD – UCLA Radiation Oncology ### 524487###Presenter###Disclosures: Employment: UCLA:Professor:Employee | Compensation: :Role Topic Description-End Date: | Ownership: MiraDx:Copyright, Ownership Equity | Leadership: MiraKind:Founder, chairperson###UCLA Radiation Oncology###Presenter: – UCLA Radiation Oncology
### 5:30 PM – 5:35 PM PT
1174 - Long-Term Results of Induction Chemotherapy Followed by 50 Gy Radiation Therapy Alone for Low-Risk HPV-Positive Oropharynx CancerLocation: Room 4Presenter: – University of Chicago
Daniel Huang, MD – University of Chicago ### 1972085###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Chicago###Presenter: – University of Chicago
### 5:35 PM – 5:40 PM PT
1176 - A Pilot, First in Human Study of Autologous IFN-Gamma Stimulated Mesenchymal Stromal Cells for Treatment of Radiation-Induced XerostomiaLocation: Room 4Presenter: – University of Wisconsin
Grace Blitzer, MD – University of Wisconsin ### 746773###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Wisconsin###Presenter: – University of Wisconsin
### 5:40 PM – 5:45 PM PT
1178 - Delta-Radiomics Guides Adaptive De-Intensification after Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma in the IMRT EraLocation: Room 4Presenter: – Sun Yat-Sen University Cancer Center
Shun-Xin Wang, MD – Sun Yat-Sen University Cancer Center ### 1972086###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Sun Yat-Sen University Cancer Center###Presenter: – Sun Yat-Sen University Cancer Center
### 5:45 PM – 5:50 PM PT
1180 - Risk-Stratification using the 40-Gene Expression Profile (40-GEP) Test Identifies Patients with Node Negative Cutaneous Squamous Cell Carcinoma (cSCC) at Higher Risk of Metastasis Who May Benefit fromLocation: Room 4Presenter: – Castle Biosciences, Inc
Anesh Prasai, PhD – Castle Biosciences, Inc ### 2082801###Presenter######Castle Biosciences, Inc###Presenter: – Castle Biosciences, Inc
### 5:15 PM – 6:15 PM PT
3213 - Effect of External Beam Radiation Therapy (EBRT) and Brachytherapy (BT) on Circulating MDSC Populations in Patients Treated Definitively for Cervical CancerLocation: Hall B1Presenter: – University of Minnesota
Kelsey Wanhainen, PhD – University of Minnesota ### 1972823###Presenter######University of Minnesota###Presenter: – University of Minnesota
###